Abstract
In right-handed patients with Parkinson's disease (PD) or isolated rapid eye movement sleep behavior disorder, dopamine transporter (DAT) [(123)I]β-carboxymethyoxy-3-β-(4-iodophenyl) tropane single photon emission computed tomography (SPECT) shows predominant nigrostriatal deficit in the left striatum. This suggests that in PD patients, the nigrostriatal system of the dominant hemisphere is more susceptible to disease-related dysfunction. To confirm this hypothesis, we investigated whether the nigrostriatal function is symmetric in healthy controls and in patients with PD. In 113 right-handed healthy controls and 279 right-handed early-PD patients, we examined the striatal dopaminergic terminals function in each hemisphere using DAT-SPECT. In the controls, DAT-SPECT showed symmetric specific binding ratios in the putamen and caudate nucleus of each hemisphere. In patients with PD, the specific binding ratio was lower in the left than in the right putamen. Right-handed healthy controls have symmetric nigrostriatal dopaminergic function. The left hemispheric predominance of nigrostriatal deficit seen in right-handed premotor and manifest PD represents an early pathological feature of the disease. © 2020 International Parkinson an...Continue Reading
References
Mar 1, 1971·Neuropsychologia·R C Oldfield
Mar 1, 1995·Neurology·C S LeeD B Calne
Jan 1, 1996·Neurology·K L MarekR P Innis
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Ana M CatafauUNKNOWN DaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group
Jun 16, 2005·Neurology·R J UittiJ D Putzke
Aug 18, 2006·Lancet Neurology·Ruth DjaldettiEldad Melamed
Mar 19, 2008·Parkinsonism & Related Disorders·Shlomit Yust-KatzRuth Djaldetti
Dec 17, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Esther CuboUNKNOWN ELEP Group Members
Sep 24, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Matthew J BarrettG Frederick Wooten
Oct 27, 2010·Parkinsonism & Related Disorders·Anouk van der HoornBauke M de Jong
Sep 21, 2011·Progress in Neurobiology·UNKNOWN Parkinson Progression Marker Initiative
Oct 14, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Anouk van der HoornBauke M de Jong
Jan 10, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Eldad Melamed, Werner Poewe
Oct 9, 2012·Brain : a Journal of Neurology·Christoph ScherflerWerner Poewe
Apr 9, 2013·Lancet Neurology·Alex IranzoJoan Santamaria
Feb 13, 2016·Neurology·Gennaro PaganoNicola Pavese
Nov 25, 2017·Nature Reviews. Neurology·Birgit HöglAleksandar Videnovic
Apr 16, 2018·Cell and Tissue Research·P RiedererR Krüger
May 2, 2018·Parkinsonism & Related Disorders·Shweta PrasadPramod Kumar Pal
Dec 20, 2018·Annals of Clinical and Translational Neurology·Kenneth MarekUNKNOWN Parkinson's Progression Markers Initiative
Oct 2, 2019·Neurology·Pietro CortelliWassilios G Meissner
Nov 15, 2019·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M Gersel StokholmN Pavese
Citations
Aug 4, 2020·Journal of Parkinson's Disease·Esther CuboUNKNOWN Coppadis Study Group:
Dec 16, 2020·Annals of Clinical and Translational Neurology·Lana M ChahineAlex Iranzo
Dec 29, 2020·Journal of Parkinson's Disease·Tadashi UmeharaYasuyuki Iguchi
Mar 23, 2021·Human Brain Mapping·Young Hee SungEung Yeop Kim
Jun 15, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Eleonora FiorenzatoRoberta Biundo
Aug 11, 2021·Brain Structure & Function·Lu-Yan GuJiali Pu
Oct 19, 2021·Frontiers in Aging Neuroscience·Mingshu MoPingyi Xu